System for Informatics in the Molecular Pathology Laboratory

Slides:



Advertisements
Similar presentations
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Advertisements

A Guide to Using Partner Publishers’ Resources (module 3)
Detection of Exon 12 Mutations in the JAK2 Gene
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival 
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes
In Silico Proficiency Testing for Clinical Next-Generation Sequencing
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes  Paula Paulo, Pedro.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
Mark G. Erlander, Xiao-Jun Ma, Nicole C
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Cystic Fibrosis The Journal of Molecular Diagnostics
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications  Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann,
Molecular Genetics of Pediatric Soft Tissue Tumors
The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR  Daniel Xia, David.
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays 
Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center  Anthony N. Sireci, Vimla S. Aggarwal, Andrew T.
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
Patrick R. Murray  The Journal of Molecular Diagnostics 
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Yuqiu Jiang, Graham Casey, Ian C
Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next- Generation Sequencing on a Four-Gene Panel  Ava Kwong, Vivian Y. Shin,
Catherine E. Cottrell, Hussam Al-Kateb, Andrew J. Bredemeyer, Eric J
Detection of Exon 12 Mutations in the JAK2 Gene
Development and Clinical Implementation of a Combination Deletion PCR and Multiplex Ligation-Dependent Probe Amplification Assay for Detecting Deletions.
Comprehensive Diagnostic Testing for Stereocilin
Catherine E. Keegan, Anthony A. Killeen 
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E
Expression of Two Breast-Specific Molecules in the Lung
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Next-Generation Sequencing for Simultaneous Determination of Human Papillomavirus Load, Subtype, and Associated Genomic Copy Number Changes in Tumors 
Utility of NIST Whole-Genome Reference Materials for the Technical Validation of a Multigene Next-Generation Sequencing Test  Bennett O.V. Shum, Ilya.
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
BRAF Mutation Testing in Solid Tumors
Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport's Syndrome  Fang Wang, Dan Zhao, Jie.
Comparison of QIAsymphony Automated and QIAamp Manual DNA Extraction Systems for Measuring Epstein-Barr Virus DNA Load in Whole Blood Using Real-Time.
The Molecular Pathology of Primary Immunodeficiencies
Serum DNA Motifs Predict Disease and Clinical Status in Multiple Sclerosis  Julia Beck, Howard B. Urnovitz, Marina Saresella, Domenico Caputo, Mario Clerici,
A Highly Sensitive Genetic Protocol to Detect NF1 Mutations
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next- Generation Sequencing Panel Testing  Wenbo Mu, Hsiao-Mei Lu, Jefferey.
A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer  Yasushi Yatabe, Toyoaki Hida, Yoshitsugu Horio, Takayuki.
Jennifer A. Hempelmann, Sheena M. Scroggins, Colin C
SeqReporter The Journal of Molecular Diagnostics
Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next- Generation Sequencing Bioinformatics and Variant Interpretation  Kurtis.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT.
External Quality Assessment for Detection of Fetal Trisomy 21, 18, and 13 by Massively Parallel Sequencing in Clinical Laboratories  Rui Zhang, Hongyun.
A Novel Long-Range PCR Sequencing Method for Genetic Analysis of the Entire PKD1 Gene  Ying-Cai Tan, Alber Michaeel, Jon Blumenfeld, Stephanie Donahue,
Genomic Technologies and the New Era of Genomic Medicine
A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick.
Molecular Monitoring of Chronic Myeloid Leukemia
Dale Muzzey, Shera Kash, Jillian I. Johnson, Laura M
Avoiding Pitfalls in Molecular Genetic Testing
Processed Pseudogene Confounding Deletion/Duplication Assays for SMAD4
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL by Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick,
Custom Design of a GeXP Multiplexed Assay Used to Assess Expression Profiles of Inflammatory Gene Targets in Normal Colon, Polyp, and Tumor Tissue  Janice.
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell- Free Tumor DNA Measurements  Hua-Jun He, Erica V. Stein, Yves Konigshofer,
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

System for Informatics in the Molecular Pathology Laboratory Wenjun Kang, Sabah Kadri, Rutika Puranik, Michelle N. Wurst, Sushant A. Patil, Ibro Mujacic, Sonia Benhamed, Nifang Niu, Chao Jie Zhen, Bekim Ameti, Bradley C. Long, Filipo Galbo, David Montes, Crystal Iracheta, Venessa L. Gamboa, Daisy Lopez, Michael Yourshaw, Carolyn A. Lawrence, Dara L. Aisner, Carrie Fitzpatrick, Megan E. McNerney, Y. Lynn Wang, Jorge Andrade, Samuel L. Volchenboum, Larissa V. Furtado, Lauren L. Ritterhouse, Jeremy P. Segal  The Journal of Molecular Diagnostics  Volume 20, Issue 4, Pages 522-532 (July 2018) DOI: 10.1016/j.jmoldx.2018.03.008 Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 The three main modules of SIMPL managing are as follows: i) Patient and Order Tracking (purple), ii) Laboratory Process Tracking (green), and iii) Genomics and Reporting (blue). Dashed rectangles represent the status gates for each test order. API, application program interface; CGL, Clinical Genomics Laboratory; Lab, laboratory; NGS, next-generation sequencing; Prep, preparation. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Test order overview page in SIMPL. This example shows mock data generated on the development server during testing of the system. The panels in order from top to bottom and left to right show patient information under “Subject Information,” order summary under “Order Information,” the status history of the order under “Order Status,” list of specimens for the test order under “Specimen Process,” run specific information under “Lab Assay,” interpretations of variants and nonvariants selected for reporting under “Variants Interpretation” and “Non-variant related interpretations,” respectively, and the top part of the text box for the order report under “Order Report,” along with the status of the report and the date on which it was uploaded to CoPath. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Variant Interpretation in SIMPL. A: The variant review page in SIMPL for an example case. Yellow boxes highlight some features of this page. The top right button can be used to regenerate the report when interpretations are modified. B: The variant interpretation window for an example IDH1 mutation in A when selected. The “View Cosmic” embedded link opens up the variant in COSMIC while the search buttons can be used to query the SIMPL database for previous interpretations of the same variant. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Matrix of pathogenic variants in the top 25% of genes in SIMPL for all hematologic (A; N = 377) and solid tumor (B; N = 708) samples that have been run on UCM-OncoPlus. ITD, internal tandem duplication; mut, mutation. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S1 Users interact with SIMPL through a web browser via HTTPS. Authenticated users by either Lightweight Directory Access Protocol (LDAP) or local accounts can access the dynamic contents through Gunicorn service. The full-text search was provided by Elasticsearch. User data are stored in the MySQL database server. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S2 SIMPL dashboard. The system is loaded with mock numbers to show the various statistics loaded on the homepage when a user logs into the system. The numbers are updated dynamically and few features are customized to users with certain roles, for example, the “My Orders” section shows the number of cases assigned to the specific user by the pathologists. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S3 Case assignment windows in SIMPL. A: The assignment home page, on which all of the cases that need to be reviewed are shown. Cases can be assigned by selecting the “+New” button. B: After selecting “New” in the Assign column, the primary reviewer and the pathologist can be assigned to the case from a drop-down menu. The Journal of Molecular Diagnostics 2018 20, 522-532DOI: (10.1016/j.jmoldx.2018.03.008) Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions